Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HVT vs HHS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HVT Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–4 Matrix Metrics)

HVT Overall Winner 6-Pillar Tally: HVT 5 – 0 HHS (1 Tie) Matrix Metrics: HVT 6 – 4 HHS

As of Nov 16, 2026, Haverty Furniture Companies, Inc. (HVT) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HVT carries a Unified Composite Score of 57.9/100 (HOLD) at $25.39 (12.7x Forward P/E, 3.1% operating margin), whereas HHS carries 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin).

  • Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HVT 57.9/100 HOLD), HVT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (3.1% vs. -3.2% operating margin) and revenue trajectory (+4.5% vs. -1.7% YoY).
  • Technical & Structure Timing Caution: HVT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.5); meanwhile HHS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 38.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HVT vs HHS
HVT NYSE Head-to-Head Winner
Haverty Furniture Companies, Inc.
Retail-Furniture Stores
$25.39
-0.04% 1D
Market Cap $405.3M
TTM Revenue $789M
Forward P/E 12.7x
Beta / 30D Vol 0.99β · 53% Vol
Unified Composite Score
57.9 / 100 HOLD
Tech 51.0 Fund 53.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.1%), weak momentum, RSI 35
RSI-14: 35.5 · SMA20: $27.86 · SMA50: $27.74
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
TTM Revenue $155M
Forward P/E 14.3x
Beta / 30D Vol 0.49β · 46% Vol
Unified Composite Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.2 · SMA20: $3.95 · SMA50: $4.26

6-Pillar Scorecard Institutional Category Breakdown (HVT 5 – 0 HHS)

Columns: Metric · HVT · HHS
1. Valuation Multiples HVT
Forward P/E 12.7x 14.3x
Trailing P/E 17.6x 14.3x
PEG Ratio 0.91x 1.19x
EV / Revenue 0.5x 0.3x
2. Growth & Scale HVT
Revenue Growth (YoY) +4.5% -1.7%
Earnings Growth (YoY) +39.3% -90.3%
TTM Revenue (USD) $789M $155M
Market Cap $405.3M $30.0M
3. Profitability & Quality HVT
Gross Margin 60.8% 16.1%
Operating Margin 3.1% -3.2%
Net Profit Margin 3.1% -3.7%
Return on Equity (ROE) 8.1% -30.4%
4. Balance Sheet & Cash Flow HVT
Cash Generation (TTM) $49M EBITDA -$4.5M
Cash Flow Margin 6.2% EBITDA Mgn -2.9%
Net Cash / Leverage $19.15 Book/Sh · 8.1% ROE $17M Net Debt (1.10x D/E)
Dividend Yield 5.03% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 35.3% (1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HVT
OpEx & R&D Intensity 57.7% of Rev ($455M) 19.3% of Rev ($30M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Home Improvement Retail Operator Conglomerates Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HVT (6) vs HHS (4)
Institutional Metric HVT HHS Criterion Row Edge
Market Capitalization
Scale
$405.3M $30.0M Larger Scale HVT
Trailing P/E Ratio
Valuation
17.6x 14.3x Lower Multiple HHS
Forward P/E Ratio
Valuation
12.7x 14.3x Lower Multiple HVT
Revenue Growth (YoY)
Growth
+4.5% -1.7% Higher Growth HVT
Operating Margin (TTM)
Profitability
3.1% -3.2% Higher Margin HVT
Net Profit Margin
Profitability
3.1% -3.7% Higher Margin HVT
Return on Equity (ROE)
Capital Efficiency
8.1% -30.4% Higher ROE HVT
52-Week Range Position
Momentum
50% ($20–$31) 69% ($2–$5) Stronger Trend HHS
Beta / 30D Volatility
Risk Regime
0.99β · 53% Vol 0.49β · 46% Vol Lower Realized Risk HHS
Unified Institutional Score
Composite Signal
57.9 / 100 (HOLD) 61.8 / 100 (BUY) Higher Composite HHS
Trailing 12M Revenue (USD)
Operating Scale
$789M $155M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
60.8% 16.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.91x PEG · 0.5x EV/Rev 1.19x PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$49M EBITDA ($19.15 Book/Sh · 8.1% ROE) -$4.5M ($17M Net Debt (1.10x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HVT +0.85 pp
HVT: -9.64% · HHS: -10.49%
3M Horizon HHS +6.65 pp
HVT: -10.41% · HHS: -3.76%
6M Horizon HHS +21.8 pp
HVT: +14.37% · HHS: +36.17%
1Y Horizon HHS +24.11 pp
HVT: +10.63% · HHS: +34.74%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HVT vs HHS. Trailing 12-month operating profitability (HVT 3.1% vs HHS -3.2%) and valuation multiples (HVT 12.7x vs HHS 14.3x Forward P/E) are benchmarked directly in Pillar 4 below.

HVT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$789M
Gross Margin60.8%
Op. Margin3.1%
ROE / Fwd P/E8.1% · 12.7x
HHS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin16.1%
Op. Margin-3.2%
ROE / Fwd P/E-30.4% · 14.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HVT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 35.3%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HVT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HVT Moat Profile Cyclical / Execution-Driven Positioning
Home Improvement Retail Operator
Competes within the Home Improvement Retail value chain with $405.3M market capitalization and 3.1% operating margin.
OpEx & R&D Reinvestment 57.7% of Rev ($455M)
90D Engineering Disclosures 0 Published
HHS Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $30.0M market capitalization and -3.2% operating margin.
OpEx & R&D Reinvestment 19.3% of Rev ($30M)
90D Engineering Disclosures 0 Published

Investor FAQ HVT vs HHS Key Questions & Quantitative Answers

As of Nov 16, 2026, Haverty Furniture Companies, Inc. (HVT) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HVT carries a Unified Composite Score of 57.9/100 (HOLD) at $25.39 (12.7x Forward P/E, 3.1% operating margin), whereas HHS carries 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. HVT 57.9/100 HOLD), HVT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (3.1% vs. -3.2% operating margin) and revenue trajectory (+4.5% vs. -1.7% YoY). Technical & Structure Timing Caution: HVT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.5); meanwhile HHS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 38.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HVT leads the Growth & Scale pillar: HVT posts +4.5% YoY revenue growth and +39.3% YoY earnings growth on $789M TTM revenue (60.8% gross margin, 3.1% operating margin), compared with HHS at -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin). On trailing 12-month operating scale, HVT generates $789M in USD-normalized revenue versus $155M for HHS. In operating R&D and SG&A reinvestment, HVT deploys 57.7% of Rev ($455M) (0 90-day corporate R&D disclosures) versus 19.3% of Rev ($30M) (0 disclosures) for HHS.

HVT screens cheaper on headline valuation multiples. HVT trades at 12.7x Forward P/E, 17.6x Trailing P/E, 0.91x PEG, and 0.5x EV/Revenue (6.2% EBITDA margin), whereas HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HVT (8.1% ROE) versus HHS (-30.4% ROE) capital efficiency.

In options market volatility and institutional positioning, HVT carries 35.3% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.99β · 53% Vol realized risk). By comparison, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.